Outcomes. (A) Swimmer plot representing postinfusion course for each of the enrolled patients. (B) Summary of response and relapses. Kaplan-Meier curves for 12-month OS with 12 patients at risk and 3 events (C), 12-month EFS with event being nonresponse, morphologic relapse, or death, with 12 patients at risk and 4 events (D), and 12-month “stringent EFS,” with events being nonresponse, morphologic relapse, or emergence of MRD level disease, death, and need for further therapy, with 12 patients at risk and 7 events (E). Ag, antigen.